October 13, 2009
Drug resistance is outpacing the discovery of new medicines, undermining the ability to treat infectious diseases in developing countries—and in wealthy countries, too. In a new working paper commissioned to inform the recommendations of a CGD working group, Prashant Yadav shows how changes in supply-chain business practices could slow the emergence and transmission of drug-resistant pathogens.